Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
filingDate |
2007-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_190fe1d4fb2c7d0235ee5af81a7a8455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcc73373241241b2d2c83d2a2294b8b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1f8c659ec19b42e9b6c8899e6a3b64f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60ec03c251aa58c26ac69f4f1966d426 |
publicationDate |
2009-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-101495109-A |
titleOfInvention |
Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin reuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
abstract |
A subject-matter of the present invention is pharmaceutical compositions comprising, in combination, at least one active ingredient chosen from (S)-(-)-N-[4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide and pharmaceutically acceptable salts there and at least one second active ingredient chosen from selective serotonin reuptake inhibitors, serotonin/norepinephrine reuptake inhibitors and pharmaceutically acceptable salts thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104666291-A |
priorityDate |
2006-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |